3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Lymphoma, Large B-Cell, Diffuse
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Lymphoma
14
Lymphoma, Non-Hodgkin
10
Lymphoma, Follicular
8
Lymphoma, B-Cell
8
Lymphoma, Mantle-Cell
7
Burkitt Lymphoma
7
Rhabdomyosarcoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Recurrence
5
Leukemia
5
Immunoblastic Lymphadenopathy
5
Lymphoma, T-Cell, Peripheral
4
Lymphoma, Large-Cell, Anaplastic
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Sarcoma, Ewing
3
Lymphoma, Primary Effusion
3
Sarcoma
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Osteosarcoma
2
Neuroblastoma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Hodgkin Disease
2
Enteropathy-Associated T-Cell Lymphoma
2
Interventions
repotrectinib
1
pralsetinib
1
pamiparib
1
Vincristine
1
Temozolomide
1
Radiotherapy
1
Radiation
1
Maintenance Chemotherapy
1
Lomustine
1
Interleukin-12
1
Cisplatin
1
Afatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Neuroectodermal Tumors
×
Vincristine
×
Clear all
NCT01614132
2020-03-31
NOA-07
University of Regensburg
Phase 1/2
Completed
33 enrolled